Market Overview:
The global NSAIDs drug market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of chronic diseases, rising geriatric population, and growing demand for pain relief drugs. By type, ibuprofen is expected to dominate the market during the forecast period owing to its high demand and widespread use for various indications such as pain relief, fever reduction, and anti-inflammatory purposes. Naproxen is also expected to witness high growth during the forecast period due to its properties such as analgesic effects and anti-inflammatory effects. By application, hospitals are estimated to account for a major share of the global NSAIDs drug market in 2018 owingtothe increasing number of surgeries being performed across the globe coupled with rising incidence rates of chronic diseases that require regular hospitalization.
Product Definition:
Nonsteroidal anti-inflammatory drugs (NSAIDs) are a class of drugs that include aspirin, ibuprofen, and naproxen. They are used to treat pain, inflammation, and fever.
Ibuprofen:
Ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) and is used for the treatment of pain, inflammation, and fever. It has been approved by the Food and Drug Administration (FDA) for use in humans as well as animals. The drug was first synthesized by Dr. August Wolff in 1969; it was patented under US Patent 3,867 of February 17, 1974 which expired on January 6, 2023 in any event.
Naproxen:
Naproxen is an NSAID used to treat pain and inflammation. It works by decreasing the production of prostaglandins, which causes pain. Naproxen sodium is a form of naproxen used for the treatment of arthritis and rheumatoid arthritis, as well as an analgesic (pain killer).
Application Insights:
The global NSAIDs market has been bifurcated into hospitals and non-sterile clinics or pharmacies. Hospitals held the largest share of over 70.0% in 2017 owing to the high usage of these drugs for pain management in surgical as well as chronic conditions, such as osteoarthritis, rheumatoid arthritis and juvenile arthritis. The growing geriatric population is also expected to contribute significantly towards hospital segment growth during the forecast period.
Non-sterile clinics or pharmacies hold a significant share owing to their ability to provide relief from acute pain without requiring an appointment hours before scheduled appointments, flexibility in choosing the time for taking medicines, availability of 24*7 online consultation with pharmacists and availability of generic medicines compared with expensive brand name drugs available at hospitals only.
Regional Analysis:
North America was the largest regional market for NSAIDs in 2017. The region is expected to maintain its dominance over the forecast period as well. This can be attributed to rising COVID-19 positive cases and subsequent coronavirus related deaths, which has resulted in an increased demand for pain management therapy across this region. In addition, growing awareness about COVID-19 and high healthcare expenditure are some of the factors that are anticipated to drive growth during the forecast period from 2018 to 2030.
Asia Pacific is anticipated to be one of fastest growing regions during the forecast period owing with increasing product availability at a lower price compared with other regions due low manufacturing cost of labor and raw material used in its production process (eg., China). Moreover, economic development coupled with improving healthcare infrastructure is also expected fuel growth over this seven year period.
Growth Factors:
- Increasing incidence of chronic diseases: The global prevalence of chronic diseases is increasing at an alarming rate. This is primarily because of the changing lifestyles and dietary habits of people across the world. As a result, there is an increased demand for drugs that can help in the treatment and management of these conditions. NSAIDs are one such class of drugs that are widely used for this purpose.
- Growing awareness about the benefits of NSAIDs: There has been a growing awareness about the benefits offered by NSAIDs in recent years, especially among healthcare professionals and patients alike. This has led to an increase in their use for various medical conditions, thereby driving growth in the market for these drugs.
- Rising geriatric population: The global geriatric population is growing at a rapid pace and this is expected to continue over the next few decades as well. This presents a major opportunity for players operating in the market for NSAIDs as this segment typically requires more specialized care and consumes more medications than other age groups do..
Scope Of The Report
Report Attributes
Report Details
Report Title
NSAIDs Drug Market Research Report
By Type
Ibuprofen, Naproxen
By Application
Hospitals, Clinics, Drugstores
By Companies
Pfizer, GSK, Grunenthal, Bayer, Sanofi, Eli Lilly, AstraZeneca, Endo, Merck, Depomed, Yunnan Baiyao, Teva, J&J, Allergan, Purdue
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
182
Number of Tables & Figures
128
Customization Available
Yes, the report can be customized as per your need.
Global NSAIDs Drug Market Report Segments:
The global NSAIDs Drug market is segmented on the basis of:
Types
Ibuprofen, Naproxen
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Drugstores
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Pfizer
- GSK
- Grunenthal
- Bayer
- Sanofi
- Eli Lilly
- AstraZeneca
- Endo
- Merck
- Depomed
- Yunnan Baiyao
- Teva
- J&J
- Allergan
- Purdue
Highlights of The NSAIDs Drug Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Ibuprofen
- Naproxen
- By Application:
- Hospitals
- Clinics
- Drugstores
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the NSAIDs Drug Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
NSAIDs are a class of drugs that reduce inflammation and pain. They are often used to treat conditions such as arthritis, menstrual cramps, and headaches.
Some of the major players in the nsaids drug market are Pfizer, GSK, Grunenthal, Bayer, Sanofi, Eli Lilly, AstraZeneca, Endo, Merck, Depomed, Yunnan Baiyao, Teva, J&J, Allergan, Purdue.
The nsaids drug market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 NSAIDs Drug Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 NSAIDs Drug Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 NSAIDs Drug Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the NSAIDs Drug Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global NSAIDs Drug Market Size & Forecast, 2018-2028
4.5.1 NSAIDs Drug Market Size and Y-o-Y Growth
4.5.2 NSAIDs Drug Market Absolute $ Opportunity
Chapter 5 Global NSAIDs Drug Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 NSAIDs Drug Market Size Forecast by Type
5.2.1 Ibuprofen
5.2.2 Naproxen
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global NSAIDs Drug Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 NSAIDs Drug Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Drugstores
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global NSAIDs Drug Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 NSAIDs Drug Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America NSAIDs Drug Analysis and Forecast
9.1 Introduction
9.2 North America NSAIDs Drug Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America NSAIDs Drug Market Size Forecast by Type
9.6.1 Ibuprofen
9.6.2 Naproxen
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America NSAIDs Drug Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Drugstores
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe NSAIDs Drug Analysis and Forecast
10.1 Introduction
10.2 Europe NSAIDs Drug Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe NSAIDs Drug Market Size Forecast by Type
10.6.1 Ibuprofen
10.6.2 Naproxen
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe NSAIDs Drug Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Drugstores
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific NSAIDs Drug Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific NSAIDs Drug Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific NSAIDs Drug Market Size Forecast by Type
11.6.1 Ibuprofen
11.6.2 Naproxen
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific NSAIDs Drug Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Drugstores
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America NSAIDs Drug Analysis and Forecast
12.1 Introduction
12.2 Latin America NSAIDs Drug Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America NSAIDs Drug Market Size Forecast by Type
12.6.1 Ibuprofen
12.6.2 Naproxen
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America NSAIDs Drug Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Drugstores
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) NSAIDs Drug Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) NSAIDs Drug Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) NSAIDs Drug Market Size Forecast by Type
13.6.1 Ibuprofen
13.6.2 Naproxen
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) NSAIDs Drug Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Drugstores
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 NSAIDs Drug Market: Competitive Dashboard
14.2 Global NSAIDs Drug Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Pfizer
14.3.2 GSK
14.3.3 Grunenthal
14.3.4 Bayer
14.3.5 Sanofi
14.3.6 Eli Lilly
14.3.7 AstraZeneca
14.3.8 Endo
14.3.9 Merck
14.3.10 Depomed
14.3.11 Yunnan Baiyao
14.3.12 Teva
14.3.13 J&J
14.3.14 Allergan
14.3.15 Purdue
